- Home
- CASI vs XOS Comparison
CASI vs XOS Comparison
Compare CASI & XOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASI
- XOS
- Stock Information
- Founded
- CASI 1991
- XOS 2016
- Country
- CASI China
- XOS United States
- Employees
- CASI N/A
- XOS N/A
- Industry
- CASI Biotechnology: Pharmaceutical Preparations
- XOS Construction/Ag Equipment/Trucks
- Sector
- CASI Health Care
- XOS Consumer Discretionary
- Exchange
- CASI Nasdaq
- XOS Nasdaq
- Market Cap
- CASI 29.7M
- XOS 30.1M
- IPO Year
- CASI 1996
- XOS N/A
- Fundamental
- Price
- CASI $1.89
- XOS $3.30
- Analyst Decision
- CASI Strong Buy
- XOS Buy
- Analyst Count
- CASI 1
- XOS 5
- Target Price
- CASI $4.00
- XOS $8.80
- AVG Volume (30 Days)
- CASI 7.1K
- XOS 20.8K
- Earning Date
- CASI 05-16-2025
- XOS 05-14-2025
- Dividend Yield
- CASI N/A
- XOS N/A
- EPS Growth
- CASI N/A
- XOS N/A
- EPS
- CASI N/A
- XOS N/A
- Revenue
- CASI $31,368,000.00
- XOS $48,678,000.00
- Revenue This Year
- CASI N/A
- XOS $3.96
- Revenue Next Year
- CASI N/A
- XOS $37.96
- P/E Ratio
- CASI N/A
- XOS N/A
- Revenue Growth
- CASI 8.39
- XOS N/A
- 52 Week Low
- CASI $1.64
- XOS $2.73
- 52 Week High
- CASI $7.67
- XOS $9.15
- Technical
- Relative Strength Index (RSI)
- CASI 47.25
- XOS 39.92
- Support Level
- CASI $1.77
- XOS $3.23
- Resistance Level
- CASI $1.98
- XOS $3.47
- Average True Range (ATR)
- CASI 0.10
- XOS 0.23
- MACD
- CASI 0.01
- XOS -0.04
- Stochastic Oscillator
- CASI 54.55
- XOS 8.64
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
About XOS Xos Inc.
Xos Inc is a fleet electrification solutions provider committed to the decarbonization of commercial transportation. Xos designs and manufactures Classes 5 through 8 battery-electric commercial vehicles that travel on last-mile, back-to-base routes of up to 200 miles per day. Xos also offers charging infrastructure products and services through Xos Energy Solutions to support electric vehicle fleets. Its products include Stepvan, MDXT, HDXT, Xosphere, and Xos Energy Solutions.